Literature DB >> 18280620

Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004.

R Sebastian1, D M Skowronski, M Chong, J Dhaliwal, J S Brownstein.   

Abstract

The influenza immunization program in North America has been primarily designed to provide direct benefit to vaccinated individuals at highest risk of serious influenza outcomes. Some evidence suggests that immunization of certain age groups may also extend indirect protective benefit to vulnerable populations. Our goal was to identify age groups associated earliest with seasonal influenza activity and who may have the greatest indirect impact at the population level. We examined age-based associations between influenza medical visits and population-wide hospitalization/mortality due to pneumonia &amp; influenza (P&amp;I) using administrative datasets in British Columbia, Canada. A peak week was identified for each age group based on the highest rates observed in a given week for that study year. Mean rates at the peak week were averaged over the study years per age group. Timeliness (T) was defined as the mean difference in days between the first peak in influenza medical visits and population-wide P&amp;I hospitalizations/deaths. Poisson regression was applied to calculate prediction (Pr) as the average proportion of deviance in P&amp;I explained by influenza medical visits. T and Pr were derived by age group, and the product (T x Pr) was used as a summary measure to rank potential indirect effects of influenza by age group. Young children (0-23 months) and the elderly (> or = 65 years) had the highest peak rates of P&amp;I hospitalization. Children < 6m and the elderly had the highest peak rates of P&amp;I mortality. We found no significant differences by age for influenza medical visits in predicting population-wide P&amp;I hospitalizations or deaths. School-aged children (5-19 years) showed the best relative combination of T x Pr, followed by preschool-aged children (2-4 years). We conclude that the very young and old suffer the greatest morbidity due to P&amp;I, and an indirect role for school-aged children in anticipating the risk to others warrants further evaluation.

Entities:  

Mesh:

Year:  2007        PMID: 18280620      PMCID: PMC2376828          DOI: 10.1016/j.vaccine.2007.11.090

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  33 in total

1.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

Authors:  L Simonsen; M J Clarke; L B Schonberger; N H Arden; N J Cox; K Fukuda
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

2.  The impact of influenza epidemics on mortality: introducing a severity index.

Authors:  L Simonsen; M J Clarke; G D Williamson; D F Stroup; N H Arden; L B Schonberger
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

3.  Potential cost savings attributable to influenza vaccination of school-aged children.

Authors:  T White; S Lavoie; M D Nettleman
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

Review 4.  Prevention of influenza in the general population.

Authors:  Joanne M Langley; Marie E Faughnan
Journal:  CMAJ       Date:  2004-11-09       Impact factor: 8.262

5.  Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age.

Authors:  J P Fox; C E Hall; M K Cooney; H M Foy
Journal:  Am J Epidemiol       Date:  1982-08       Impact factor: 4.897

6.  Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

Authors:  L G Rudenko; A N Slepushkin; A S Monto; A P Kendal; E P Grigorieva; E P Burtseva; A R Rekstin; A L Beljaev; V E Bragina; N Cox
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

7.  Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.

Authors:  W H Barker
Journal:  Am J Public Health       Date:  1986-07       Impact factor: 9.308

8.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

Authors:  K L Nichol; K L Margolis; J Wuorenma; T Von Sternberg
Journal:  N Engl J Med       Date:  1994-09-22       Impact factor: 91.245

9.  Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic.

Authors:  A S Monto; F M Davenport; J A Napier; T Francis
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.

Authors:  Pedro A Piedra; Manjusha J Gaglani; Claudia A Kozinetz; Gayla Herschler; Mark Riggs; Melissa Griffith; Charles Fewlass; Matt Watts; Colin Hessel; Julie Cordova; W Paul Glezen
Journal:  Vaccine       Date:  2005-02-18       Impact factor: 3.641

View more
  14 in total

1.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

2.  Using age, triage score, and disposition data from emergency department electronic records to improve Influenza-like illness surveillance.

Authors:  Noémie Savard; Lucie Bédard; Robert Allard; David L Buckeridge
Journal:  J Am Med Inform Assoc       Date:  2015-02-26       Impact factor: 4.497

3.  Physician surveillance of influenza: collaboration between primary care and public health.

Authors:  David Price; David Chan; Nancy Greaves
Journal:  Can Fam Physician       Date:  2014-01       Impact factor: 3.275

4.  Contact, Travel, and Transmission: The Impact of Winter Holidays on Influenza Dynamics in the United States.

Authors:  Anne Ewing; Elizabeth C Lee; Cécile Viboud; Shweta Bansal
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

5.  Age-Specific Patterns of Influenza Activity in Utah: Do Older School Age Children Drive the Epidemic?

Authors:  Chris Stockmann; Andrew T Pavia; Adam L Hersh; Michael G Spigarelli; Brooks Castle; Kent Korgenski; Carrie L Byington; Krow Ampofo
Journal:  J Pediatric Infect Dis Soc       Date:  2013-02-14       Impact factor: 3.164

6.  Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents.

Authors:  Jean-Eric Tarride; Natasha Burke; Camilla Von Keyserlingk; Daria O'Reilly; Feng Xie; Ron Goeree
Journal:  Clinicoecon Outcomes Res       Date:  2012-10-04

7.  Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics?

Authors:  Dena Schanzer; Julie Vachon; Louise Pelletier
Journal:  Am J Epidemiol       Date:  2011-05-20       Impact factor: 4.897

8.  Age as a determinant for dissemination of seasonal and pandemic influenza: an open cohort study of influenza outbreaks in Östergötland County, Sweden.

Authors:  Toomas Timpka; Olle Eriksson; Armin Spreco; Elin A Gursky; Magnus Strömgren; Einar Holm; Joakim Ekberg; Orjan Dahlström; Lars Valter; Henrik Eriksson
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Population-based hospitalization burden of influenza a virus subtypes and antigenic drift variants in children in Hong Kong (2004-2011).

Authors:  Susan S Chiu; Janice Y C Lo; Kwok-Hung Chan; Eunice L Y Chan; Lok-Yee So; Peng Wu; Benjamin J Cowling; Robin Chen; J S Malik Peiris
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

10.  Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.

Authors:  Megan K L Macleod; Alexandria David; Niyun Jin; Laura Noges; Jieru Wang; John W Kappler; Philippa Marrack
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.